Back to News
research

Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Lonza will divest 60% of its Capsules & Health Ingredients (CHI) business to Lone Star Funds, accelerating its shift to a pure-play contract development and manufacturing organization (CDMO). The deal marks the most significant step in Lonza’s 18-month transformation, streamlining operations to focus exclusively on high-margin CDMO services for biopharma and healthcare sectors. CEO Wolfgang Wienand emphasized the strategic move aligns with Lonza’s "One Lonza" vision, prioritizing core competencies in drug development and manufacturing over commoditized capsule production. Financial terms were not disclosed, but the divestment is expected to enhance profitability and operational efficiency, with proceeds likely reinvested in CDMO expansion and R&D. The transaction requires regulatory approval, with closing anticipated in late 2026, pending standard antitrust reviews and final negotiations.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (18).png
Quantum News · Media Library

SA Transcripts158.89K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation March 9, 2026 3:00 AM EDT Company Participants Wolfgang Wienand - Chief Executive OfficerPhilippe Deecke - Chief Financial Officer Conference Call Participants Charles Weston - RBC Capital Markets, Research Division Presentation Operator Ladies and gentlemen, welcome to the Lonza Investor Conference Call. I am Sandra, the Chorus Call operator. [Operator Instructions] The conference is being recorded. [Operator Instructions] The conference must not be recorded for publication or broadcast. At this time, it is my pleasure to hand over to Wolfgang Wienand, CEO. Please go ahead, sir. Wolfgang WienandChief Executive Officer Yes. Thank you, Sandra, and hello, welcome to this short update call. I'm Wolfgang Wienand, the CEO of Lonza and together with me in the room is our CFO, Philippe Deecke. This actually is the second edition of this investor call and somewhat unusual setup, but we wanted to make sure that we share news in a timely manner, news of our agreement to divest our Capsules & Health Ingredients business to Lone Star Funds and make sure that actually everyone has an opportunity to join and to listen to our thoughts. In this call, we will share further details of the divestment and then take some time to answer your questions. Before we move on, please take a few moments to review our safe harbor statement. I'm sure you are all already aware of its terms, and I encourage you to ensure they are observed. Let me start with a short set of highlights relating to the transaction and our high-speed progress to create a pure-play One Lonza CDMO over the last 1.5 years. Our agreement to sell 60% of CHI to Lone Star is the most significant and indeed the

Read Original

Tags

government-funding
quantum-algorithms

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.